Brief: EQL Pharma Resolves On A Rights Issue Of Approximately SEK 24.9 mln
17/10/2018 16:53
Oct 17 (Reuters) - EQL Pharma AB EQL.TE :
* EQL PHARMA RESOLVES ON A RIGHTS ISSUE OF APPROXIMATELY SEK
24.9
MILLION AND ANNOUNCES CHANGED DATE FOR PUBLICATION OF THE Q2
INTERIM REPORT TO 18TH OCTOBER, 2018
Source text for Eikon: ID:nWkr4qLyyM
Further company coverage: EQL.TE
(Reporting by Stockholm Newsroom)
((stockholm.newsroom@thomsonreuters.com; +4687001017;))